Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

1.5K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.5K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

2.6K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.6K
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

302
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
302
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

304
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
304
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

1.4K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.4K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

1.3K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug Dosing in Post-Dilution Hemodiafiltration: Pharmacokinetic Principles and Clinical Implications.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Physical Activity in Short Daily Home Dialysis vs to In-Center HD: Results from the Self-convecTive Evaluation of Short Daily Home Dialysis on Physical Activity Study.

Kidney360·2026
Same author

Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE.

PloS one·2026
Same author

Hemodialysis Modality and Mortality Outcomes among Incident Dialysis Patients: An International Cohort Study Comparing High-Volume Hemodiafiltration and Hemodialysis.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Continuous monitoring of relative blood volume allows real-time assessment of intradialytic hypotension risk.

Clinical kidney journal·2026
Same author

A Randomized Control Trial of MuST for Vascular Access Cannulation in Hemodialysis Patients: Contributions for a Safe Nursing Intervention.

Kidney medicine·2026

Related Experiment Video

Updated: Mar 10, 2026

A Small Volume Procedure for Viral Concentration from Water
07:28

A Small Volume Procedure for Viral Concentration from Water

Published on: February 3, 2015

10.7K

What Is the Optimal Target Convective Volume in On-Line Hemodiafiltration Therapy?

Bernard Canaud, Katrin Koehler, Sudhir Bowry

    Contributions to Nephrology
    |December 13, 2016
    PubMed
    Summary

    Hemodiafiltration (HDF) offers improved removal of large toxins compared to standard hemodialysis for end-stage chronic kidney disease (ESKD) patients. Optimizing the convective dose in HDF is key to enhancing patient outcomes and represents a significant advancement in renal replacement therapy.

    More Related Videos

    Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
    07:59

    Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

    Published on: July 28, 2018

    11.8K
    An Open-Source Normothermic Perfusion System Designed for Research Scientists
    11:23

    An Open-Source Normothermic Perfusion System Designed for Research Scientists

    Published on: July 18, 2025

    1.3K

    Related Experiment Videos

    Last Updated: Mar 10, 2026

    A Small Volume Procedure for Viral Concentration from Water
    07:28

    A Small Volume Procedure for Viral Concentration from Water

    Published on: February 3, 2015

    10.7K
    Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
    07:59

    Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

    Published on: July 28, 2018

    11.8K
    An Open-Source Normothermic Perfusion System Designed for Research Scientists
    11:23

    An Open-Source Normothermic Perfusion System Designed for Research Scientists

    Published on: July 18, 2025

    1.3K

    Area of Science:

    • Nephrology
    • Renal Replacement Therapy
    • Biomedical Engineering

    Background:

    • Conventional dialysis struggles to remove large uremic toxins, impacting end-stage chronic kidney disease (ESKD) patient outcomes.
    • Hemodiafiltration (HDF) enhances solute removal by increasing convective transport, addressing limitations of diffusion-based methods.
    • Chronic kidney disease (CKD) is associated with morbidity and mortality linked to toxin accumulation and inflammation.

    Purpose of the Study:

    • To explore the concept of convective dose in hemodiafiltration (HDF).
    • To identify the threshold convective dose for improved ESKD patient outcomes.
    • To review factors and best practices for achieving an optimal convective dose in HDF.

    Main Methods:

    • Review of clinical evidence on HDF and its association with patient outcomes.
    • Stratification of convective volumes into minimal, optimal, personalized, and maximal efficacy levels.
    • Analysis of factors influencing the achievement of optimal convective dose.

    Main Results:

    • HDF demonstrates superior removal of middle- and large-size uremic toxins compared to conventional hemodialysis.
    • Clinical benefits of HDF are positively correlated with the total ultrafiltered volume (convective dose).
    • Optimal convective dose is crucial for improving ESKD patient outcomes.

    Conclusions:

    • HDF offers a paradigm shift in renal replacement therapy for ESKD patients.
    • Optimizing convective dose is essential for maximizing the clinical benefits of HDF.
    • HDF provides improved hemodynamic stability and reduced inflammation in ESKD patients.